APA (7th ed.) Citation

Schachar, R. A., Raber, S., Courtney, R., & Zhang, M. (2011). A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension. Current Eye Research, 36(9), 809. https://doi.org/10.3109/02713683.2011.593725

Chicago Style (17th ed.) Citation

Schachar, Ronald A., Susan Raber, Rachel Courtney, and Min Zhang. "A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension." Current Eye Research 36, no. 9 (2011): 809. https://doi.org/10.3109/02713683.2011.593725.

MLA (9th ed.) Citation

Schachar, Ronald A., et al. "A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension." Current Eye Research, vol. 36, no. 9, 2011, p. 809, https://doi.org/10.3109/02713683.2011.593725.